Surpassing Apple Fitness, a Virtual Unknown Wins Best Health App of the Year
A lifesaving breast health app named 'Know Your Lemons' wins top prize—with extra features for the workplace to support employees...
Genetic Testing
Genomic Prediction Files Federal Lawsuit to Protect Trade Secrets and Intellectual Property and Enforce Its Rights
NEWARK, N.J., Oct. 23, 2025 /PRNewswire/ -- Genomic Prediction Inc. ("GP"), a leader in advanced genetic testing and reproductive genomics, announced...
Inception Fertility Commends President Trump for Encouraging Employers to Expand Fertility Benefits
In a press conference, the President called on US employers to expand healthcare benefits to include IVF HOUSTON, Oct. 17,...
A.D.A.M. Innovations and SOPHiA GENETICS partner to advance liquid biopsy testing and companion diagnostics for precision oncology in Japan
ROLLE, Switzerland and TOKYO, Oct. 16, 2025 /PRNewswire/ -- A.D.A.M. Innovations, Japan's leading private genetic testing company, and SOPHiA GENETICS (Nasdaq: SOPH),...
Illumina constellation mapped read technology uncovers hard-to-see genomic insights in GeneDx pilot
Illumina's up-and-coming constellation innovation delivers accuracy, speed, and ease of use in trial by GeneDx Constellation outperformed orthogonal methods in...
TruDiagnostic Awarded NIH SBIR Grant to Advance Breakthrough Epigenetic Diagnostic Technology
LEXINGTON, Ky., Oct. 7, 2025 /PRNewswire/ -- TruDiagnostic, a leader in epigenetic testing and health analytics, announced today it has...
Golden Helix Receives a NIH SBIR Phase 2 Grant
Pharmacogenomics Workflow: Identifying Biomarkers and Treatment Options BOZEMAN, Mont., Oct. 7, 2025 /PRNewswire/ -- Golden Helix, Inc. announced that it...
Hypha Labs and Tryptomics Launch Phase II of Strategic Partnership, Pairing Patented Mushroom Accelerator(TM) with World-Class Internal Quality Control & Fungal Genomics
LAS VEGAS, NV / ACCESS Newswire / October 1, 2025 / Hypha Labs, Inc. (OTCQB:FUNI), a biotechnology company pioneering the...
Quintessence Psychiatry Adopts Mentavi’s Mental Health Diagnostic Evaluation to Offer More Rigorous, Timely ADHD Assessments in Private Practice
Early Patient Feedback Points to Clearer Understanding of Results and Smoother Treatment Planning GRAND RAPIDS, MICHIGAN / ACCESS Newswire /...
SumHealth and Nucleus Genomics Partner to Bring Whole-Genome DNA Testing Into Healthcare Infrastructure
Partnership Makes Advanced, Clinical-Grade Genetic Insights Affordable and Accessible Through Hospitals, Pharmacies and Healthcare Systems Nationwide CHARLOTTE, NORTH CAROLINA /...
SumHealth and Nucleus Genomics Partner to Bring Whole-Genome DNA Testing Into Healthcare Infrastructure
Partnership Makes Advanced, Clinical-Grade Genetic Insights Affordable and Accessible Through Hospitals, Pharmacies and Healthcare Systems Nationwide CHARLOTTE, NORTH CAROLINA /...
National Ataxia Foundation Partners with Biogen to Bring Bill Nye “the Science Guy” Back To the Lab With New Series About Friedreich Ataxia
MINNEAPOLIS, Sept. 25, 2025 /PRNewswire/ -- The National Ataxia Foundation (NAF) today announced the launch of The Science Guy: Back in...
Burning Rock’s OncoGuide™ OncoScreen™ Plus CDx System Now Approved in Japan as a Companion Diagnostic for Capivasertib in Breast Cancer
TOKYO and GUANGZHOU, China, Sept. 24, 2025 (GLOBE NEWSWIRE) -- Riken Genesis Co., Ltd. (Riken Genesis) and Burning Rock Biotech...
Microbix Assisting EMQN with Second Genetic-Test EQA Program
Helping Ensure Appropriate Dosing of Widely-Used Anti-Clotting DrugsMISSISSAUGA, Ontario and MANCHESTER, United Kingdom, Sept. 23, 2025 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc....
Hydreight Technologies Signs Binding Letter of Intent to Acquire Dynamic IV Therapy Support AI Agent
Not for distribution to United States newswire services or for dissemination in the United States. VANCOUVER, British Columbia, Sept. 08, 2025...
FDA Approves LEQEMBI® IQLIK™ (lecanemab-irmb) Subcutaneous Injection for Maintenance Dosing for the Treatment of Early Alzheimer’s Disease
LEQEMBI IQLIK is the first and only anti-amyloid treatment to offer an at-home injection to help patients and care partners...
Natera Launches Proprietary AI Foundation Models to Accelerate Diagnostic and Therapeutic Innovation
Proprietary platform is built on one of the largest multimodal oncology datasets, including 250,000+ tumor exomes, 1 million+ plasma timepoints,...
Natera Launches Proprietary AI Foundation Models to Accelerate Diagnostic and Therapeutic Innovation
Proprietary platform is built on one of the largest multimodal oncology datasets, including 250,000+ tumor exomes, 1 million+ plasma timepoints,...
Ultima Genomics and Gene by Gene Partner to Expand Global Access to High-Quality, Low-Cost Sequencing on the UG 100™ Platform
Collaboration Extends Global Reach of High-Performance Genomic Sequencing on the UG 100™ Platform FREMONT, Calif. and HOUSTON, Aug. 19, 2025...
Citizen Health Raises $30 Million to Build AI Advocate for Every Patient, Ushering in a New Era of Patient-Centered Healthcare
SAN FRANCISCO, Aug. 14, 2025 /PRNewswire/ -- Citizen Health, a patient-powered platform transforming rare disease care, announced today it has...